ESMO Breast Cancer 2025 May 14 - 17, 2025 | Munich, Germany and Virtual ++++++

https://www.medscape.com/viewarticle/new-high-risk-triple-negative-breast-cancer-subgroup-2025a1000ci7?ecd=WNL_conf_onc_ESMO-NON-SPON_250527_MSCPEDIT_etid7446057&uac=148436CN&impID=7446057 Adjuvant Pertuzumab Shows OS Benefit in HER2 Breast Cancer Tara Haelle May 19, 2025 https://www.medscape.com/viewarticle/adjuvant-pertuzumab-shows-os-benefit-her2-breast-cancer-2025a1000cke?ecd=WNL_conf_onc_ESMO-NON-SPON_250527_MSCPEDIT_etid7446057&uac=148436CN&impID=7446057 Imlunestrant Benefit in Breast Cancer Holds After Progression on CDK4/6 Therapy Megan Brooks May 16, 2025 https://www.medscape.com/viewarticle/imlunestrant-benefit-breast-cancer-holds-after-progression-2025a1000cck?ecd=WNL_conf_onc_ESMO-NON-SPON_250527_MSCPEDIT_etid7446057&uac=148436CN&impID=7446057 Does Weight Gain After Breast Cancer Diagnosis Affect Outcomes? Megan Brooks May 20, 2025 https://www.medscape.com/viewarticle/does-weight-gain-after-breast-cancer-diagnosis-affect-2025a1000cp4?ecd=WNL_conf_onc_ESMO-NON-SPON_250527_MSCPEDIT_etid7446057&uac=148436CN&impID=7446057 Pregnancy Safe in Those Who Previously Had Breast Cancer While Pregnant Tara Haelle May 20, 2025 https://www.medscape.com/viewarticle/pregnancy-safe-those-who-previously-had-breast-cancer-while-2025a1000cpv?ecd=WNL_conf_onc_ESMO-NON-SPON_250527_MSCPEDIT_etid7446057&uac=148436CN&impID=7446057 https://www.medscape.com/viewcollection/37805?ecd=WNL_conf_onc_ESMO-NON-SPON_250527_MSCPEDIT_etid7446057&uac=148436CN&impID=7446057